Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Jun 15, 2006 (Vol. 26, No. 12)

Inside Plants Live

  • Interesting reading
  • Non-scientific
Blogs are getting better at disguising themselves, which isn’t all bad. When I went to Inside Plants Live, I scanned through the abundant information at the site and found it most informative to read. After I clicked on the About the Site link, I discovered I’d been actually enjoying a blog, of all things. While one might quibble with exactly what is and is not a blog, I think what matters is what the site considers itself and more importantly, the value of its content. On the latter matter I can give high marks. With monthly entries dating to 2004, articles categorized into over 20 topic areas, abundant pictures, and a lack of attitude generally linked to blogs, Inside Plants Live is one of my most pleasant finds of the year. While it is low on the science end of things, it is great reading.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »